Anti-CD19 Market, Global Outlook and Forecast 2022-2028

February 2022 | 61 pages | ID: A56325B74209EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Anti-CD19 in Global, including the following market information:

Global Anti-CD19 Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anti-CD19 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-CD19 include Thermo Fisher Scientific, R & D Systems, Bio-Rad, LifeSpan BioSciences, Abbexa Ltd, Boster Bio, Aviva Systems Biology, Biobyt and Genetex and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-CD19 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-CD19 Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anti-CD19 Market Segment Percentages, by Type, 2021 (%)

• Monoclonal
• Polyclonal
• Other

Global Anti-CD19 Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anti-CD19 Market Segment Percentages, by Application, 2021 (%)

• Mouse
• Human
• Other

Global Anti-CD19 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anti-CD19 Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-CD19 revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anti-CD19 revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• R & D Systems
• Bio-Rad
• LifeSpan BioSciences
• Abbexa Ltd
• Boster Bio
• Aviva Systems Biology
• Biobyt
• Genetex
• ProteoGenix

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-CD19 Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-CD19 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-CD19 OVERALL MARKET SIZE

2.1 Global Anti-CD19 Market Size: 2021 VS 2028
2.2 Global Anti-CD19 Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anti-CD19 Players in Global Market
3.2 Top Global Anti-CD19 Companies Ranked by Revenue
3.3 Global Anti-CD19 Revenue by Companies
3.4 Top 3 and Top 5 Anti-CD19 Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-CD19 Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-CD19 Players in Global Market
  3.6.1 List of Global Tier 1 Anti-CD19 Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anti-CD19 Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anti-CD19 Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal
  4.1.3 Polyclonal
  4.1.4 Other
4.2 By Type - Global Anti-CD19 Revenue & Forecasts
  4.2.1 By Type - Global Anti-CD19 Revenue, 2017-2022
  4.2.2 By Type - Global Anti-CD19 Revenue, 2023-2028
  4.2.3 By Type - Global Anti-CD19 Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-CD19 Market Size, 2021 & 2028
  5.1.2 Mouse
  5.1.3 Human
  5.1.4 Other
5.2 By Application - Global Anti-CD19 Revenue & Forecasts
  5.2.1 By Application - Global Anti-CD19 Revenue, 2017-2022
  5.2.2 By Application - Global Anti-CD19 Revenue, 2023-2028
  5.2.3 By Application - Global Anti-CD19 Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-CD19 Market Size, 2021 & 2028
6.2 By Region - Global Anti-CD19 Revenue & Forecasts
  6.2.1 By Region - Global Anti-CD19 Revenue, 2017-2022
  6.2.2 By Region - Global Anti-CD19 Revenue, 2023-2028
  6.2.3 By Region - Global Anti-CD19 Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anti-CD19 Revenue, 2017-2028
  6.3.2 US Anti-CD19 Market Size, 2017-2028
  6.3.3 Canada Anti-CD19 Market Size, 2017-2028
  6.3.4 Mexico Anti-CD19 Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anti-CD19 Revenue, 2017-2028
  6.4.2 Germany Anti-CD19 Market Size, 2017-2028
  6.4.3 France Anti-CD19 Market Size, 2017-2028
  6.4.4 U.K. Anti-CD19 Market Size, 2017-2028
  6.4.5 Italy Anti-CD19 Market Size, 2017-2028
  6.4.6 Russia Anti-CD19 Market Size, 2017-2028
  6.4.7 Nordic Countries Anti-CD19 Market Size, 2017-2028
  6.4.8 Benelux Anti-CD19 Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anti-CD19 Revenue, 2017-2028
  6.5.2 China Anti-CD19 Market Size, 2017-2028
  6.5.3 Japan Anti-CD19 Market Size, 2017-2028
  6.5.4 South Korea Anti-CD19 Market Size, 2017-2028
  6.5.5 Southeast Asia Anti-CD19 Market Size, 2017-2028
  6.5.6 India Anti-CD19 Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anti-CD19 Revenue, 2017-2028
  6.6.2 Brazil Anti-CD19 Market Size, 2017-2028
  6.6.3 Argentina Anti-CD19 Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anti-CD19 Revenue, 2017-2028
  6.7.2 Turkey Anti-CD19 Market Size, 2017-2028
  6.7.3 Israel Anti-CD19 Market Size, 2017-2028
  6.7.4 Saudi Arabia Anti-CD19 Market Size, 2017-2028
  6.7.5 UAE Anti-CD19 Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific Anti-CD19 Major Product Offerings
  7.1.4 Thermo Fisher Scientific Anti-CD19 Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 R & D Systems
  7.2.1 R & D Systems Corporate Summary
  7.2.2 R & D Systems Business Overview
  7.2.3 R & D Systems Anti-CD19 Major Product Offerings
  7.2.4 R & D Systems Anti-CD19 Revenue in Global Market (2017-2022)
  7.2.5 R & D Systems Key News
7.3 Bio-Rad
  7.3.1 Bio-Rad Corporate Summary
  7.3.2 Bio-Rad Business Overview
  7.3.3 Bio-Rad Anti-CD19 Major Product Offerings
  7.3.4 Bio-Rad Anti-CD19 Revenue in Global Market (2017-2022)
  7.3.5 Bio-Rad Key News
7.4 LifeSpan BioSciences
  7.4.1 LifeSpan BioSciences Corporate Summary
  7.4.2 LifeSpan BioSciences Business Overview
  7.4.3 LifeSpan BioSciences Anti-CD19 Major Product Offerings
  7.4.4 LifeSpan BioSciences Anti-CD19 Revenue in Global Market (2017-2022)
  7.4.5 LifeSpan BioSciences Key News
7.5 Abbexa Ltd
  7.5.1 Abbexa Ltd Corporate Summary
  7.5.2 Abbexa Ltd Business Overview
  7.5.3 Abbexa Ltd Anti-CD19 Major Product Offerings
  7.5.4 Abbexa Ltd Anti-CD19 Revenue in Global Market (2017-2022)
  7.5.5 Abbexa Ltd Key News
7.6 Boster Bio
  7.6.1 Boster Bio Corporate Summary
  7.6.2 Boster Bio Business Overview
  7.6.3 Boster Bio Anti-CD19 Major Product Offerings
  7.6.4 Boster Bio Anti-CD19 Revenue in Global Market (2017-2022)
  7.6.5 Boster Bio Key News
7.7 Aviva Systems Biology
  7.7.1 Aviva Systems Biology Corporate Summary
  7.7.2 Aviva Systems Biology Business Overview
  7.7.3 Aviva Systems Biology Anti-CD19 Major Product Offerings
  7.7.4 Aviva Systems Biology Anti-CD19 Revenue in Global Market (2017-2022)
  7.7.5 Aviva Systems Biology Key News
7.8 Biobyt
  7.8.1 Biobyt Corporate Summary
  7.8.2 Biobyt Business Overview
  7.8.3 Biobyt Anti-CD19 Major Product Offerings
  7.8.4 Biobyt Anti-CD19 Revenue in Global Market (2017-2022)
  7.8.5 Biobyt Key News
7.9 Genetex
  7.9.1 Genetex Corporate Summary
  7.9.2 Genetex Business Overview
  7.9.3 Genetex Anti-CD19 Major Product Offerings
  7.9.4 Genetex Anti-CD19 Revenue in Global Market (2017-2022)
  7.9.5 Genetex Key News
7.10 ProteoGenix
  7.10.1 ProteoGenix Corporate Summary
  7.10.2 ProteoGenix Business Overview
  7.10.3 ProteoGenix Anti-CD19 Major Product Offerings
  7.10.4 ProteoGenix Anti-CD19 Revenue in Global Market (2017-2022)
  7.10.5 ProteoGenix Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anti-CD19 Market Opportunities & Trends in Global Market
Table 2. Anti-CD19 Market Drivers in Global Market
Table 3. Anti-CD19 Market Restraints in Global Market
Table 4. Key Players of Anti-CD19 in Global Market
Table 5. Top Anti-CD19 Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-CD19 Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-CD19 Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-CD19 Product Type
Table 9. List of Global Tier 1 Anti-CD19 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-CD19 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-CD19 Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-CD19 Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-CD19 Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-CD19 Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-CD19 Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-CD19 Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-CD19 Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-CD19 Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-CD19 Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-CD19 Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-CD19 Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-CD19 Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-CD19 Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-CD19 Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-CD19 Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-CD19 Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-CD19 Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-CD19 Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-CD19 Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Anti-CD19 Product Offerings
Table 32. Thermo Fisher Scientific Anti-CD19 Revenue (US$, Mn), (2017-2022)
Table 33. R & D Systems Corporate Summary
Table 34. R & D Systems Anti-CD19 Product Offerings
Table 35. R & D Systems Anti-CD19 Revenue (US$, Mn), (2017-2022)
Table 36. Bio-Rad Corporate Summary
Table 37. Bio-Rad Anti-CD19 Product Offerings
Table 38. Bio-Rad Anti-CD19 Revenue (US$, Mn), (2017-2022)
Table 39. LifeSpan BioSciences Corporate Summary
Table 40. LifeSpan BioSciences Anti-CD19 Product Offerings
Table 41. LifeSpan BioSciences Anti-CD19 Revenue (US$, Mn), (2017-2022)
Table 42. Abbexa Ltd Corporate Summary
Table 43. Abbexa Ltd Anti-CD19 Product Offerings
Table 44. Abbexa Ltd Anti-CD19 Revenue (US$, Mn), (2017-2022)
Table 45. Boster Bio Corporate Summary
Table 46. Boster Bio Anti-CD19 Product Offerings
Table 47. Boster Bio Anti-CD19 Revenue (US$, Mn), (2017-2022)
Table 48. Aviva Systems Biology Corporate Summary
Table 49. Aviva Systems Biology Anti-CD19 Product Offerings
Table 50. Aviva Systems Biology Anti-CD19 Revenue (US$, Mn), (2017-2022)
Table 51. Biobyt Corporate Summary
Table 52. Biobyt Anti-CD19 Product Offerings
Table 53. Biobyt Anti-CD19 Revenue (US$, Mn), (2017-2022)
Table 54. Genetex Corporate Summary
Table 55. Genetex Anti-CD19 Product Offerings
Table 56. Genetex Anti-CD19 Revenue (US$, Mn), (2017-2022)
Table 57. ProteoGenix Corporate Summary
Table 58. ProteoGenix Anti-CD19 Product Offerings
Table 59. ProteoGenix Anti-CD19 Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anti-CD19 Segment by Type in 2021
Figure 2. Anti-CD19 Segment by Application in 2021
Figure 3. Global Anti-CD19 Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-CD19 Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-CD19 Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-CD19 Revenue in 2021
Figure 8. By Type - Global Anti-CD19 Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-CD19 Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-CD19 Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-CD19 Revenue Market Share, 2017-2028
Figure 12. US Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-CD19 Revenue Market Share, 2017-2028
Figure 16. Germany Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-CD19 Revenue Market Share, 2017-2028
Figure 24. China Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-CD19 Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-CD19 Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-CD19 Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Anti-CD19 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. R & D Systems Anti-CD19 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bio-Rad Anti-CD19 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. LifeSpan BioSciences Anti-CD19 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbexa Ltd Anti-CD19 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boster Bio Anti-CD19 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aviva Systems Biology Anti-CD19 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biobyt Anti-CD19 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Genetex Anti-CD19 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ProteoGenix Anti-CD19 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)